Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05914337Completed
Open-label trial (2 arms), sponsored by Sağlık Bilimleri Üniversitesi. Primary endpoints: Disease Activity Score 28 at 8 weeks and Gene Expressions of microRNA at 8 weeks. Started Aug 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05914337.